Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Poster for New Osmium PS with Hypoxic Phototoxicity

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Mar 03, 2021 12:04pm

191 Views

Post# 32705314

RE:RE:Poster for New Osmium PS with Hypoxic Phototoxicity

You said it Fred. Also - "The latest addition to Theralase's Intellectual Property Portfolio, which will eventually make it an irresistible buyout target"

fredgoodwinson wrote:
Thanks again Eog - the title says it all really: ‘Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy’.

If only the poster could add - ‘coming soon to a melanoma near you’.